J. Yau

1.0k citations

19 papers · 700 indexed · h-index 13

Impact in

Oncology top 10%
- Viral-associated cancers and disorders
Health Informatics top 10%

Papers in

Health Informatics 1
Oncology 12
- Cancer Treatment and Pharmacology 3
- Lung Cancer Research Studies 3

Co-authors: Christina Richard John P.H. Th'ng Valentina Evdokimova Poul H. Sorensen Maxim A. Skabkin Alexey V. Sorokin Sergey Guryanov Lev P. Ovchinnikov
Journals: Annals of Oncology (3 papers)Journal of Clinical Oncology (2 papers)Cancer (1 paper)Stem Cells (1 paper)Investigational New Drugs (1 paper)
Partner nations: United States Canada Spain

In The Last Decade

J. Yau

19 papers receiving 693 citations

Peers

Countries citing papers authored by J. Yau

Since Specialization

Citations

This map shows the geographic impact of J. Yau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Yau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Yau more than expected).

Fields of papers citing papers by J. Yau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Yau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Yau. The network helps show where J. Yau may publish in the future.

Co-authorship network

The 25 scholars most cited alongside J. Yau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. Yau Line = papers co-authored together J. Yau links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Noninvasive Monitoring Techniques in the Pregnant Heart Transplant Patient The Journal of Heart and Lung Transplantation ·Hianny Jhosy Martins Marques, J. Yau, Z Khan, Luana Peixoto Borges, J. F. Collins Lyndon A. Yose, Gregg Zimmer, Luciana Scanapieco Queiroz, Nicola Jones, Fatwa Perdana Panjaitan, 岡馬恵介, Gautam Ramani, Yu Fu, Machado Glauco, Kenyatta Jeter	2025	1
2	Accuracy of Prospective Assessments of 4 Large Language Model Chatbot Responses to Patient Questions About Emergency Care: Experimental Comparative Study Journal of Medical Internet Research ·J. Yau, Soheil Saadat, K. Sugapriya, Linda Murphy, Cristiane Olivieri, Jeffrey R. Suchard, 滕典春, Warren Wiechmann, Mark I. Langdorf	2024	15
3	A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors Journal of Molecular Diagnostics ·Rajyalakshmi Luthra, Keyur P. Patel, Mark J. Routbort, Russell R. Broaddus, J. Yau, Muhammad Riyan Al Muhdi, Wei Chen, 友男琉子, L. Jeffrey Medeiros, Rajesh R. Singh	2016	61
4	Phase I study of Aplidine in a daily×5 one-hour infusion every 3 weeks in patients with solid tumors refractory to standard therapy. A National Cancer Institute of Canada Clinical Trials Group study: NCIC CTG IND 115 Annals of Oncology ·J. Maroun, K. Bélanger, Lesley Seymour, S. Matthews, James Roach, Hasan Yanik, Denis Soulières, David J. Stewart, Rakesh Goel, Danielle Charpentier, Glenwood Goss, Eva Tomiak, J. Yau, José Jimeno, 重善青井	2006	51
5	Sensitivity of 5-fluorouracil-resistant cancer cells to adenovirus suicide gene therapy Cancer Gene Therapy ·Christina Richard, Wilhelmina Duivenvoorden, Denis Bourbeau, B. Massie, Wilson Roa, J. Yau, John P.H. Th'ng	2006	22
6	Proteasome‐mediated cleavage of the Y‐box‐binding protein 1 is linked to DNA‐damage stress response The EMBO Journal ·Alexey V. Sorokin, 성유창, Maxim A. Skabkin, Sergey Guryanov, I. V. Nazimov, Christina Richard, John P.H. Th'ng, J. Yau, Poul H. Sorensen, Lev P. Ovchinnikov, Valentina Evdokimova	2005	132
7	Flavopiridol Sensitivity of Cancer Cells Isolated from Ascites and Pleural Fluids Clinical Cancer Research ·Christina Richard, Donald G. Matthews, Wilhelmina Duivenvoorden, J. Yau, Paul S. Wright, John P.H. Th'ng	2005	15
8	Gemcitabine, dexamethasone and cisplatin is an active andnon-toxic chemotherapy regimen in relapsed or refractory Hodgkin’s disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group Annals of Oncology ·Tara Baetz, Andrew R. Belch, Stephen Couban, Kevin Imrie, J. Yau, Robert E. Myers, Keyue Ding, Narinder Paul, L. E. Shepherd, José Iglesias, Ralph M. Meyer, Michael Crump	2003	120
9	Accuracy of The Oncology Patients Information System in a regional cancer centre Oncology Reports ·J. Yau, Arlene Chan, J R x ED os-Blanco, Francesca Magbitang Gambalosa, Libni Eapen	2002	7
10	A phase I dose escalation study of the matrix metalloproteinase inhibitor BAY 12-9566 administered orally in patients with advanced solid tumours Annals of Oncology ·Hal W. Hirte, Rakesh Goel, Pierre Major, Leonard W. Seymour, S. Huan, Donna E. Stewart, J. Yau, Andrew Arnold, Huan Huang, Eileen Capponi, Susan E. Bates, Katherine Bennett, William R. Walsh, Boris Waschkowski	2000	32
11	Concurrent use of multiple chemotherapy resistance modulators with etoposide in patients with resistant malignancies International Journal of Oncology ·Donald Stewart, Rajesh Kumar Goel, M. Christine Cripps, J. Yau, S. Huan, Eva Tomiak, Ross A. Davies, Hélène Dulude, G. Gallant	1997	2
12	168 A pilot study of high dose chemotherapy and irradiation with NEUPOGEN (G-CSF) in limited disease small cell lung cancer (SCLC) Lung Cancer ·Greg G. Goss, C. Lochrin, S. Gertler, 貴志永田, P. Cross, M. Gerlagh, Heny Kusuma Widyaningrum, Silvana Spadafora, R.J Olsen, Gregory Bociek, Peng Li, J. Yau	1997	1
13	Active vs. passive resistance, dose-response relationships, high dose chemotherapy, and resistance modulation: a hypothesis Investigational New Drugs ·Reinder Pieters, G. P. Raaphorst, J. Yau, Kimihio Yasuda	1996	29
14	Cyclosporin plus doxorubicin, vincristine and etoposide in the treatment of refractory non-Hodgkin's lymphoma: A phase II study Clinical Oncology ·David Moore, F Swan, J. Yau, María Carmen Rodriguez, Peter McLaughlin, A H Sarris, Jorge Romaguera, Anas Younes, A. Buddendiek, Fernando Cabanillas	1995	5
15	Effect of schedule and maintenance on the antiemetic efficacy of ondansetron combined with dexamethasone in acute and delayed nausea and emesis in patients receiving moderately emetogenic chemotherapy: a phase III trial by the National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology ·L Kaizer, David Warr, Paul Hoskins, Jean Latreille, W. Lofters, J. Yau, Michael Palmer, Benny Zee, Maurice Levy, Joseph L. Pater	1994	92
16	Intensive combination chemotherapy and autologous bone marrow transplantation leads to the reappearance of philadelphia chromosome-negative cells in chronic myelogenous leukemia Cancer ·Hagop M. Kantarjian, C. Frederick LeMaistre, Jorge A. Spinolo, Gary Spitzer, J. Yau, Karel A. Dicke, Sundar Jagannath, Albert Deisseroth, Moshe Talpaz	1991	28
17	Ectopic pituitary transplants restore immunocompetence in Ames dwarf mice European Journal of Endocrinology ·Ana I. Esquifino, M.A. Villanúa, B. Jacobsson, J. Yau, Andrzej Bartke	1991	33
18	A phase II study of mitoxantrone, etoposide, and thiotepa with autologous marrow support for patients with relapsed breast cancer. Journal of Clinical Oncology ·Ralph O. Wallerstein, Gary Spitzer, Frank Dunphy, S. Huan, Gabriel N. Hortobágyi, J. Yau, Aman U. Buzdar, Frankie A. Holmes, Richard L. Theriault, Michael S. Ewer	1990	43
19	Use of recombinant human hematopoietic growth factors and autologous bone marrow transplantation to attenuate the neutropenic trough of high-dose therapy Stem Cells ·Gary Spitzer, Albert Deisseroth, Gerard J. Ventura, Sundar Jagannath, Priyadarshani H.E.N, Kerry Taylor, S. Huan, Frank Dunphy, Karel A. Dicke, J. Yau, Raquel Delgado García, Jorge A. Spinolo, G. Amutha	1990	11

About J. Yau

J. Yau is a scholar working on Health Informatics, Oncology, Biotechnology, Health Information Management and Cancer Research, having authored 19 papers that have together received 700 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (4 papers), Cancer Treatment and Pharmacology (3 papers), Lung Cancer Research Studies (3 papers), Neuroendocrine Tumor Research Advances (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Lung Cancer Treatments and Mutations (2 papers), Nausea and vomiting management (1 paper) and Virus-based gene therapy research (1 paper). The work is most often cited by research in Oncology (275 citations), Health Informatics (12 citations), Pathology and Forensic Medicine (152 citations), Cancer Research (108 citations) and Genetics (60 citations). J. Yau has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Christina Richard, John P.H. Th'ng, Valentina Evdokimova, Poul H. Sorensen, Maxim A. Skabkin, Alexey V. Sorokin, Sergey Guryanov, Lev P. Ovchinnikov, I. V. Nazimov and Michael Crump. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Cancer, Stem Cells and Investigational New Drugs.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact